Chakshushya effect of ayurvedic drugs and therapies in refractive errors wrt myopia
Phase 3
- Conditions
- Health Condition 1: H538- Other visual disturbances
- Registration Number
- CTRI/2023/04/051438
- Lead Sponsor
- Dr Richa Mohan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients willing for trial
2.Patients presenting with signs and symptoms of Timira/Myopia.
3.Age group between 10-25 years
4.Patient having SIMPLE MYOPIA i.e. having power Diopter up to -6.0D with no associated ocular anomaly
Exclusion Criteria
1.Patients not willing for trial
2.Any other refractive error
3.Any systemic disease like hypertension, diabetes, gout, rheumatoid arthritis,sinusitis, anaemia or any kind of heart disease
4.Pathological/Congenital/Acquired myopia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br/ ><br>â?¢ To study the efficacy of drugs and procedure and life style modifications in the management of Timira/ myopia <br/ ><br> <br/ ><br>. <br/ ><br>Timepoint: 0,1st week,2nd week,3rd week,4th week ,15 days after course
- Secondary Outcome Measures
Name Time Method <br/ ><br> <br/ ><br>â?¢To study the effect of tarpana with triphala ghrita in the management of Timira <br/ ><br>â?¢To study the effect of eye exerecises on eye muscles. <br/ ><br> <br/ ><br>Timepoint: 0,ist week, 2nd week, 3rd week, 4th week, 15 days after trial
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the Chakshushya effect of Saptamrit lauha and Triphala ghrita tarpana in myopia management?
How does the combination of Saptamrit lauha and Triphala ghrita tarpana compare to standard myopia treatments in clinical efficacy?
Are there specific biomarkers that correlate with response to Ayurvedic therapies for Timira in phase III trials?
What adverse events are associated with Saptamrit lauha and Triphala ghrita tarpana in ophthalmic applications?
What are the potential synergies between Ayurvedic compounds like Triphala ghrita and modern myopia correction therapies?